Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

NCT06711978 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

CIPN
CIPN - Chemotherapy-Induced Peripheral Neuropathy
CIPN in Adjuvant Breast Cancer Patients
Duloxetine
Mirogabalin

Interventions

DRUG: Mirogabalin
DRUG: Duloxetine

Sponsor

Pusan National University Yangsan Hospital